检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:郭晴 田庆丰[1] 朱春燕 张鲁玉 GUO Qing(College of Public Health,Zhengzhou University,Zhengzhou,Henan,450001,China)
出 处:《医学与社会》2021年第1期14-19,共6页Medicine and Society
基 金:国家重点研发计划课题,编号为2016YFC0106900、2016 YFC0106907;中国经济改革促进与能力加强项目,编号为20180429A、20180430A。
摘 要:目的:分析我国2002-2018年公立医院人均住院费用和药占比的变化趋势并进行预测,为公立医院价格综合改革提供依据。方法:采用EVIEWS 10.0和MATLAB 2018a软件分别建立ARIMA模型和GM(1,1)模型,预测我国2019-2025年人均住院费用和药占比的变化趋势。结果:采用ARIMA(1,1,1)模型和GM(1,1)模型对人均住院费用预测的平均绝对误差分别为64.544、145.563,平均相对误差分别为0.010、0.022;采用ARIMA(1,2,0)模型和GM(1,1)模型对人均药占比预测的平均绝对误差分别为0.889、2.894,平均相对误差分别为0.023、0.072,因此本研究中ARIMA模型的预测误差小。2025年患者人均住院费用预计为12315元,药占比预计达到10.6%。结论:2002-2025年我国患者人均住院费用逐年增加,增速减缓;药占比逐年下降。今后应继续推行医药卫生体制改革和药品组合政策,控制不合理用药,减轻患者疾病经济负担。Objective:To analyze the changing trend of the per capita hospitalization expenses and the proportion of drugs in public hospitals from 2002 to 2018,and to make a prediction,so as to provide a basis for the comprehensive price reform of public hospitals.Methods:EVIEWS 10.0 and MATLAB 2018a software were used to establish ARIMA model and GM(1,1)model to predict the changing trend of the per capita hospitalization expenses and drug proportion in China from 2019 to 2025.Results:The average absolute errors of the ARIMA(1,1,1)model and GM(1,1)model were 64.544 and 145.563,respectively.The average relative errors were 0.010 and 0.022,respectively.The average absolute errors of ARIMA(1,2,0)model and GM(1,1)model were 0.889 and 2.894,respectively.The mean relative errors were 0.023 and 0.072,respectively,and the error of ARIMA model was small.In 2025,the average hospitalization expense of patients is estimated to be 12315 yuan,and the proportion of drugs is estimated to be 10.6%.Conclusion:From 2002 to 2025,the per patient hospitalization expenses in China increased year by year,and the growth rate slowed down.The proportion of drugs decreased year by year.In the future,we should continue to carry out the reform of the medical and health system and the policy of drug combination,control irrational drug use and reduce the economic burden of disease on patients.
分 类 号:R19-0[医药卫生—卫生事业管理]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.170